Promote Sponsor
verified SJR 5,557 · Q1 • database Scopus / SJR & Web of Science indexed
Hepatology
United States · Lippincott Williams and Wilk...
workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access Unclaimed

Hepatology

Hepatology is a journal indexed in SJR in Medicine (miscellaneous) and Hepatology with an H index of 415. It has a price of 1900 €. It has an SJR impact factor of 5,557 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,557.

Hepatology focuses its scope in these topics and keywords: hepatitis, virus, liver, patients, chronic, cells, hepatocellular, factor, injury, infection, ...

ISSN: 0270-9139
Editorial: Lippincott Williams and Wilkins
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
5,557 Q1
H-index 415
Tasa de Aceptación pie_chart
16% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
1.900 € Open Access
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

5,557

H-index

415

Docs (year)

576

Docs 3y

1581

Total refs

22271

Cites 3y

14591

Citable 3y

999

Cites/Doc 2y

9.55

Ref/Doc

38.66

Immediate OA

1900 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers

View more

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

View more

Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome

View more

Critical flicker frequency for quantification of low-grade hepatic encephalopathy

View more

Cost-effectiveness analysis of hepatitis A vaccination strategies for adults

View more

Correlation Between Liver Morphology and Portal Pressure in Alcoholic Liver Disease

View more

Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with anmdr1agene disruption

View more

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin

View more

Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis

View more

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C

View more

Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study

View more

Chemokine systems and hepatitis C virus infection: Is truth in the genes of the beholders?

View more
SHOW MORE ARTICLES

Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method

View more

1204 Early HCV kinetics in immunosuppressed patients undergoing antiviral therapy: OLT vs. HIV-HCV coinfected vs. normal patients

View more

Autoimmunity after liver transplantation

View more

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

View more

Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

View more

An economic analysis of different strategies of immunization against hepatitis a virus in developed countries

View more

Advances in bioartificial liver devices

View more

Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity

View more

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients

View more

Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome

View more

A sheep in wolf's clothing

View more

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

View more

FAQS